Geode Capital Management’s BioCardia BCDA Stock Holding History
Bought
Maintained
Sold
Other funds holding BCDA
CM
PP
Geode Capital Management's BCDA Position: Q2 2026 in Review
Geode Capital Management reduced its BioCardia (BCDA) stake by 29% in Q2 2026, selling an estimated $29.1K and leaving 66,664 shares worth $82.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4134.
Geode Capital Management first reported a position in BCDA in Q4 2020 and has held it in 23 quarters since. The position peaked at $388K in Q2 2023. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.
- Geode Capital Management held 66,664 shares of BioCardia worth $82.7K as of Q2 2026.
- Geode Capital Management sold 27,623 BioCardia shares in Q2 2026, an estimated $29.1K.
- BioCardia made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4134 holding.
- Geode Capital Management first reported a position in BioCardia in Q4 2020 and has held it in 23 quarters since.
- Geode Capital Management's BioCardia position peaked at $388K in Q2 2023.
- 21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.